openPR Logo
Press release

23-Valent Pneumococcal Polysaccharide Vaccine Market to Perceive Substantial Growth During 2017-2023 : Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co. and Other Top Key Players Included

02-08-2019 02:13 PM CET | Health & Medicine

Press release from: Allied Market Research

23-Valent Pneumococcal Polysaccharide Vaccine Market

23-Valent Pneumococcal Polysaccharide Vaccine Market

Pneumococcal is an infectious disease caused by the streptococcus pneumoniae bacteria. Pneumococcal may cause different types of illnesses such as ear infection, meningitis, and others. There are vaccines available that can prevent pneumococcal infection such as pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine. Pneumococcal polysaccharide vaccines are recommended mostly for adults who suffer from pneumococcal infection.

Increase in geriatric population, rise in the incidence of bacterial infections, and advancements in medical technology are the major factors that drive the market growth. However, stringent government regulations for the approval of vaccines are expected to restrain the market growth. Improvement in healthcare facilities in emerging regions such as Asia-Pacific and LAMEA is expected to provide new growth opportunities for the market during the analysis period.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/3985

The 23-Valent pneumococcal polysaccharide vaccine market is segmented on the basis of dose type, age-group, and geography. Based on dose type the market is segmented into single dose vial and pre-filled syringe. Based on age-group the market is divided into children (2-10 years), adults (10-64 years), and geriatrics (65 years and above). By geography, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

• The study provides an in-depth analysis of the global 23-valent pneumococcal polysaccharide vaccine market, with current trends and future estimations to elucidate investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
• The report offers a quantitative analysis to assist stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments determines various products available in the market.
• Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.

23-valent Pneumococcal Polysaccharide Vaccine Market Key Segments:

By Dose Type

• Single Dose Vial
• Pre-Filled Syringe

By Age-Group

• Children (2-10 years)
• Adults (10-64 years)
• Geriatrics (65 years and above)

For More Info Visit @ https://www.alliedmarketresearch.com/23-valent-pneumococcal-polysaccharide-vaccine-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 23-Valent Pneumococcal Polysaccharide Vaccine Market to Perceive Substantial Growth During 2017-2023 : Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co. and Other Top Key Players Included here

News-ID: 1573219 • Views:

More Releases from Allied Market Research

Mapping Strategies for Electrical Steel Market Growth 2024-2027: Size and Share, Opportunity Forecast
Mapping Strategies for Electrical Steel Market Growth 2024-2027: Size and Share, …
The global electrical steel industry generated $15.0 billion in 2019, and is projected to generate $21.0 billion by 2027, portraying a CAGR of 5.8% from 2020 to 2027. Allied Market Research published a report, titled, "Electrical Steel Market by Type (Grain Oriented Electrical Steel and Non-Grain Oriented Electrical Steel) and Application (Transformers, Motors, Generators, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027." Download Sample Report in PDF Format (MUST SEE): https://www.alliedmarketresearch.com/request-sample/7533 Prime determinants of growth Surge in demand
Strategies for Thriving in the Technical Ceramics Market 2024, Size, Share, Trends and Opportunities 2026
Strategies for Thriving in the Technical Ceramics Market 2024, Size, Share, Tren …
The global technical ceramics industry was estimated at $8.03 billion in 2018 and is anticipated to register $13.09 billion by 2026, registering a CAGR of 6.2% during the period 2019 to 2026. Rise in demand from several end-use industries and emergence of technical ceramics as a substitute to metal drive the growth of the global technical ceramics market. On the other hand, high energy costs for manufacturing technical ceramics impede
Strategies for Success in the Supplementary Cementitious Materials Market 2024 to 2030
Strategies for Success in the Supplementary Cementitious Materials Market 2024 t …
The global supplementary cementitious materials market generated $20.1 billion in 2020, and is expected to reach $39.9 billion by 2030, witnessing at a CAGR of 7.2% from 2021 to 2030. According to the report published by Allied Market Research, The Supplementary Cementitious Materials Market by Type (Fly Ash, Slag Cement, and Silica Fume) and Application (Residential, Commercial and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030. The Supplementary Cementitious Materials Market report
Mapping Strategies for Liquid Packaging Market Growth 2024-2027: Size and Share, Opportunity Forecast
Mapping Strategies for Liquid Packaging Market Growth 2024-2027: Size and Share, …
According to the report, the global liquid packaging industry generated $331.8 billion in 2019, and is expected to generate $463.2 billion by 2027, witnessing a CAGR of 4.5% from 2020 to 2027. Allied Market Research published a report, titled, "Liquid Packaging Market by Material (Paperboard, Plastics, Glass, Metal, and Others), Technology (Aseptic Liquid Packaging, Blow Molding, and Form Fill Seal), Packaging Format (Flexible and Rigid), and End-user (Food & Beverage,

All 5 Releases


More Releases for Pneumococcal

Global To Invigorate The Intravenous Pneumococcal Vaccines Market
Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine. The Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all children younger than two years of age, all adults 65 years or older, and for people 2-64 years old with certain medical conditions. The CDC recommends pneumococcal polysaccharide vaccine for all
Pneumococcal Vaccines Market Demands and Gross Margin 2027
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry
Pneumococcal and Meningococcal Vaccines Market Analysis by Industry 2020
The Pneumococcal & Meningococcal Vaccines Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and New innovations. The report contains a granular analysis of the present industry situations, market demands, reveal
Pneumococcal Vaccine Report on Global Pneumococcal Vaccine Market Development, p …
Latest Survey on Pneumococcal Vaccine Market: The Global Pneumococcal Vaccine market report value has been estimated considering the application and regional segments, market share, and size, while the forecast for each product type and application segment has been provided for the global markets. The Pneumococcal Vaccine report offers detailed profiles of the key players to bring out a clear view of the competitive landscape of the Pneumococcal Vaccine Outlook. It also
Pneumococcal Vaccines Market | North America Dominated the Global Market
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Global Pneumococcal Vaccine Industry Market Analysis & Forecast 2018-2023
Global Pneumococcal Vaccine Industry Market results in aggravation noticeable all around sacs (known as alveoli) of the lungs, which brings about filling the alveoli with liquid (discharge cells), accordingly causing breathing issues. Pneumococcal Vaccine illness is regular in youthful youngsters, however more established grown-ups are at most serious danger of genuine pneumococcal diseases and even demise. Get sample copy of report: https://www.marketdensity.com/contact?ref=Sample&reportid=4396 Table of Contents 1 Industry Overview 1.1 Pneumococcal Vaccine Industry 1.1.1